ePrints

Digitoxin, at concentrations commonly found in the plasma of cardiac patients, antagonizes etoposide and idarubicin activity in K562 leukemia cells

Lookup NU author(s): Dr Miguel Lopez-Lazaro, Sami Azrak, Professor Caroline AustinORCiD

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Abstract

Digitoxin is used in the treatment of cardiac congestion and some types of cardiac arrhythmias. The mechanism of action of this cardiac glycoside suggested that it might antagonize the anticancer activity of topoisomerase II poisons. The present report shows that digitoxin, at concentrations commonly found in the plasma of cardiac patients, significantly reduced etoposide and idarubicin-induced topoisomerase II cleavable complexes in K562 leukemia cells. This may lead to a reduction in the anticancer effect of these two topoisomerase II poisons when they are used in the clinic concurrently with digitoxin. © 2005 Elsevier Ltd. All rights reserved.

Publication metadata

Author(s): Lopez-Lazaro M, Pastor N, Azrak SS, Ayuso MJ, Cortes F, Austin CA

Publication type: Article

Publication status: Published

Journal: Leukemia Research

Year: 2006

Volume: 30

Issue: 7

Pages: 895-898

ISSN (print): 0145-2126

ISSN (electronic): 1873-5835

Publisher: Pergamon

URL: http://dx.doi.org/10.1016/j.leukres.2005.11.005

DOI: 10.1016/j.leukres.2005.11.005

PubMed id: 16387358

Altmetrics

Share